{"title":"How Can We Improve Gynecological Surgery Webinars during the COVID-19 Pandemic?","authors":"W S Felix Wong, Thomas Kwok To Li","doi":"10.4103/gmit.gmit_140_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_140_21","url":null,"abstract":"<p><p>The COVID-19 pandemic prevented doctors from attending surgical meetings or conferences where they learned surgical skills from others and shared surgical experiences. It also resulted in the rapid use of webinars in obstetrics and gynecology meetings. While webinars or virtual meetings enable distance learning and replace face-to-face meetings using various teleconferencing software programs, many attendees are not satisfied and find it difficult to learn surgical techniques using commercially available telecommunication programs. Therefore, dedicated webinars are necessary to present emerging surgical technologies, satisfy the attendees, and achieve a successful outcome. This article reviews the existing telecommunication programs, new presentation technologies, and proposed webinars developments to improve its delivery of surgical techniques and training during the COVID-19 pandemic and in the future.</p>","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"193-197"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/5e/GMIT-11-193.PMC9844047.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10554174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tugba Kinay, Yasemin Kizilkaya, Sadiman Kiykac Altinbas, Omer Lutfi Tapisiz, Yaprak Engin Ustun
{"title":"Feasibility and Safety of Laparoscopic Surgery in Large Ovarian Masses.","authors":"Tugba Kinay, Yasemin Kizilkaya, Sadiman Kiykac Altinbas, Omer Lutfi Tapisiz, Yaprak Engin Ustun","doi":"10.4103/gmit.gmit_122_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_122_21","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the feasibility and safety of laparoscopic surgery for large ovarian masses with benign features.</p><p><strong>Materials and methods: </strong>Women who underwent laparoscopic surgery for an ovarian mass with benign features between 2017 and 2019 at a tertiary referral center were included in the retrospective study. Based on the size of the ovarian mass, the women were divided into the case and control groups of ≥10 cm and <10 cm, respectively. Clinical characteristics, operative findings, histopathological results, and complication rates of the groups were compared.</p><p><strong>Results: </strong>A total of 260 women, 64 women with large masses and 196 with small masses were included in the study. The operation time, intraoperative cyst rupture rate, complication rate, and hospital stay were similar in the case and control groups (<i>P</i> > 0.05). The cyst aspiration rate (29.7% vs. 5.1%, <i>P</i> < 0.001) and the unexpected malignancy rate (7.8% vs. 0.0% <i>P</i> = 0.001) were significantly higher in the case group than in the control group.</p><p><strong>Conclusion: </strong>Laparoscopic surgery was found feasible for the treatment of women with large ovarian masses. However, a higher unexpected malignancy rate requires the careful patient selection and appropriate counseling preoperatively in these cases.</p>","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"215-220"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/a1/GMIT-11-215.PMC9844044.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10554182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Influence of Uterine Cavity Breach in Laparoscopic Myomectomy on the Risk of Obstetric Complications.","authors":"Shinichiro Wada, Yoshiyuki Fukushi, Yosuke Ono, Hajime Ota, Yoko Tsuzuki, Hideto Yamada","doi":"10.4103/gmit.gmit_146_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_146_21","url":null,"abstract":"<p><strong>Objectives: </strong>Prepregnancy myomectomy is effective for the treatment of infertility or prevention of obstetric complications and is usually performed with laparoscopy. However, pregnancies following myomectomy have risks of obstetric complications, especially in cases with uterine cavity breaches, but the evidence remains unclear. We investigated how uterine cavity breach in laparoscopic myomectomy influenced the occurrence of obstetric complications.</p><p><strong>Patients and methods: </strong>One hundred and eighty women who underwent a cesarean section from 2014 to 2020 in pregnancies following laparoscopic myomectomy were included. They were divided into two groups: 25 women in the uterine cavity breach group and 155 in the nonbreach group. Obstetric complications, including placenta accreta spectrum (PAS), uterine rupture, placental malposition, abruption placenta, preterm delivery, threatened premature labor, premature rupture of membranes, and massive intrapartum hemorrhage, were assessed.</p><p><strong>Results: </strong>Multivariate analysis revealed that the frequency of PAS in the breach group (24.0%) was statistically significantly higher than in the nonbreach group (5.2%, <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>This study demonstrated that women who experienced uterine cavity breach in laparoscopic myomectomy had an increased risk of PAS in subsequent pregnancies.</p>","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"221-223"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/c5/GMIT-11-221.PMC9844043.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10554177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tamer E El-Ghazaly, Ibrahim A Abdelazim, A Elshabrawy
{"title":"Intrauterine Levobupivacaine Instillation for Pain Control in Women Undergoing Diagnostic Hysteroscopy.","authors":"Tamer E El-Ghazaly, Ibrahim A Abdelazim, A Elshabrawy","doi":"10.4103/gmit.gmit_48_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_48_21","url":null,"abstract":"<p><strong>Objectives: </strong>Many women experience pain and discomfort after hysteroscopic procedure. Pain and discomfort after hysteroscopic procedures can be explained by the cervical dilatation, intrauterine manipulation, and/or hydrodistension. This study designed to evaluate the efficacy of intrauterine levobupivacaine instillation for pain control in women undergoing diagnostic hysteroscopy.</p><p><strong>Materials and methods: </strong>One hundred and twenty (120) women scheduled for diagnostic hysteroscopy and endometrial biopsy due to uterine bleeding were included in this study and randomized either to levobupivacaine group or controls. At the end of hysteroscopy, 5 mL of 0.5% levobupivacaine was instilled intrauterine in levobupivacaine group, while 5 mL of 0.9% saline was instilled intrauterine in controls. Participants were kept in the hospital for 12 h after diagnostic hysteroscopy to detect the postoperative (PO) pain intensity using visual analog scale (VAS), and PO required analgesics.</p><p><strong>Results: </strong>The VAS was significantly lower in levobupivacaine group compared to controls 3 h. PO (1.31 ± 1.02 vs. 1.62 ± 0.76, respectively), (<i>P</i> = 0.01), 6 h. PO (0.81 ± 1.24 vs. 1.53 ± 0.88, respectively), (<i>P</i> = 0.004), and 9 h. PO (0.55 ± 1.25 vs. 1.12 ± 0.95, respectively), (<i>P</i> = 0.01). The total PO required analgesics were significantly lower in levobupivacaine group compared to controls (<i>P</i> = 0.005).</p><p><strong>Conclusion: </strong>The intrauterine levobupivacaine instillation was simple, and effective for pain relief after diagnostic hysteroscopy, it significantly decreased pain score assessed by VAS at 3, 6, and 9 h., PO, and it significantly decreased PO required analgesics.</p>","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"209-214"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/32/GMIT-11-209.PMC9844048.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10554181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rebecca Chou, Jessica Robertson, Mujahid Bukhari, Danny Chou
{"title":"Uterine Teratoma (Dermoid cyst) Presenting as an Endometrial Polyp.","authors":"Rebecca Chou, Jessica Robertson, Mujahid Bukhari, Danny Chou","doi":"10.4103/gmit.gmit_107_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_107_21","url":null,"abstract":"On the initial diagnostic hysteroscopy, the lesion appeared as an endometrial polyp [Figure 1]; however, on resection of the lesion, fatty tissue was identified in its core [Figures 2 and 3 and Supplementary Video 1]. There was no evidence of uterine perforation. Histology was reported to be a mature benign uterine teratoma. There were areas of adipose tissue, neural tissue, bone and cartilage, as well as hair-bearing squamous epithelium.","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"256-257"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e3/ba/GMIT-11-256.PMC9844045.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10607223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Choriocarcinoma of the Ovary Masquerading as Ectopic Pregnancy.","authors":"Roopa Malik, Menka Verma, Meenakshi Chauhan, Pooja Sinha","doi":"10.4103/gmit.gmit_93_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_93_21","url":null,"abstract":"<p><p>Choriocarcinoma of ovary is a rare aggressive tumor of ovary. It may be gestational or nongestational tumor. High index of suspicion is required for diagnosis in reproductive age group females. Here, we present a case report of a 30-year-old female who was operated for ectopic pregnancy but was diagnosed as ovarian choriocarcinoma on histopathology. The patient had abnormally high beta-human chorionic gonadotropin levels with history of amenorrhea and negative urine pregnancy test. On laparotomy, a mass of 8 cm × 10 cm was found which was confirmed as choriocarcinoma on histopathological examination. The patient was managed with chemotherapy and responded well to treatment.</p>","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"247-249"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/25/8d/GMIT-11-247.PMC9844049.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10607224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Laparoscopic Operation Under Hysteroscopic Guidance in Management of Cesarean Scar Defect.","authors":"Hoang The Dinh, An Nguyen Phuong Tran","doi":"10.4103/gmit.gmit_113_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_113_21","url":null,"abstract":"setting The progressive increase in the rate of cesarean sections has led to rapid growth in the proportion of cesarean scar defect (CSD) recently, which creates an enormous burden for the healthcare systems in the world.[1] In this case, the patient she is a 35‐year‐old woman, G1P1 with postmenstrual bleeding and secondary infertility (repeated embryo transfer failure) which are caused by large CSD.","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"242-243"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/45/GMIT-11-242.PMC9844046.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10554176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Manuel Gonçalves-Henriques, António de Pinho, Marília Freixo, Maria Liz-Coelho, Fabiana Castro, Nathan Ceschin, Pedro Brandão
{"title":"Ulipristal Acetate in Adenomyosis.","authors":"Manuel Gonçalves-Henriques, António de Pinho, Marília Freixo, Maria Liz-Coelho, Fabiana Castro, Nathan Ceschin, Pedro Brandão","doi":"10.4103/gmit.gmit_95_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_95_21","url":null,"abstract":"<p><p>Adenomyosis is defined as the invasion of the basal endometrium (stroma and glands) into the underlying myometrium. It may lead to abnormal uterine bleeding (AUB), pelvic pain, and infertility. The definitive treatment is hysterectomy. Some conservative measures have been used in patients willing to procreate. Ulipristal acetate is a selective progesterone receptor modulator used to treat AUB caused by leiomyomas. This is a systematic review on the use of ulipristal to treat adenomyosis. Eight eligible articles were retrieved from PubMed, SCOPUS, and Cochrane Library. Only one randomized clinical trial was published until date concerning this matter. It seems that ulipristal acetate induces partial or complete remission of AUB caused by adenomyosis, but the evidence concerning its effect on pelvic pain and the radiologic findings of the disease is conflicting. Nevertheless, given the paucity of data, it is still preliminary to draw any conclusion about the subject.</p>","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"198-202"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/8b/GMIT-11-198.PMC9844051.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10607227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Salivary Proteome Profile during the Fertile Phase of Menstrual Cycle: Correspondence.","authors":"Pathum Sookaromdee, Viroj Wiwanitkit","doi":"10.4103/gmit.gmit_130_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_130_21","url":null,"abstract":"We would like to share ideas on “Salivary proteome profile of women during the fertile phase of menstrual cycle as characterized by mass spectrometry.”[1] Saibaba et al. concluded that “Total salivary proteome profile has been listed .... validation is required before arriving to a candidate bio‐marker protein.”[1] We agree that there is potential that salivary proteome might be a useful biomarker. In laboratory medicine, there are many considerations on accuracy and interference of salivary proteome biomarker. Contamination is easy and specimen collection needs a good procedure. In the present report, tooth brushing is used for preparation. However, other sources of interferences such as food and drink as well as quality of tooth brushing and toothpaste should be discussed. Furthermore, underlying physiological condition of the subjects might interfere salivary proteome profile. Nutritional status of subjects might also affect the profile.[2] Further studies to assess those confounding factors are interesting.","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"258"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b4/ab/GMIT-11-258.PMC9844040.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10554175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Incidental Aggressive Angiomyxoma of the Vulva: Looks can be Deceptive.","authors":"Akanksha Tripathi, Shikha Sharma, Sunil Kanvinde","doi":"10.4103/gmit.gmit_72_21","DOIUrl":"https://doi.org/10.4103/gmit.gmit_72_21","url":null,"abstract":"<p><p>Aggressive angiomyxoma is a benign, slow-growing, locally aggressive tumor of mesenchymal origin primarily occurring in the pelvic-perineal regions of reproductive age group women and displays a high risk of local recurrence. Lack of specific symptomatology and overlap with other benign and malignant vulval masses makes it a diagnostic challenge. We describe the case of a 32-year-old nulliparous woman with a history of recurrent vulval abscess requiring multiple incision and drainage procedures before she presented to us with an actively draining abscess on the upper third of the left labia majora. She underwent excisional biopsy at our center, the histopathology of which revealed aggressive angiomyxoma with secondary pyogenic slough. The preoperative diagnosis of vulval aggressive angiomyxoma becomes challenging due to the absence of diagnostic features. It ought to be considered a differential in every perineal-pelvic region mass in adult women.</p>","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"11 4","pages":"253-255"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/5a/GMIT-11-253.PMC9844041.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10554179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}